Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers
Suna Önengüt-Gümüşcü(University of Virginia), Stephen S. Rich(Virginia Department of Health), Chris Wallace(University of Cambridge), Hui Guo(Henan University of Traditional Chinese Medicine), Nick J. Cooper(National Institute for Health and Care Research), Jessica Bonnie(University of Virginia), Oliver S. Burren(AstraZeneca (United Kingdom)), Jeffrey C. Barrett(Wellcome Sanger Institute), Mary D Fortune(National Institute for Health and Care Research), Michał Szpak(University of Virginia), Ellen Schofield(National Institute for Health and Care Research), Neil Walker, Aaron R. Quinlan(Pacific Biosciences (United States)), Patrick Concannon(University of Florida), Emily Farber(University of Virginia), Panos Deloukas(Queen Mary University of London), Anshul Kundaje(Stanford University), Wei‐Min Chen(University of Virginia), Premanand Achuthan(National Institute for Health and Care Research), Lucas D. Ward(Alnylam Pharmaceuticals (United States)), Jason D. Cooper(National Institute for Health and Care Research), M Kellis(University of Science and Technology of China), Helen Stevens(National Institute for Health and Care Research), John A. Todd(University of Oxford), Mark Daly(Harvard University), Josyf C. Mychaleckyj(University of Virginia Health System)
Cited by 744
Related Papers
Initial sequencing and analysis of the human genome
|Nature|2001|24.6k
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
|Nature|2007|9.6k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k